Abstract:The global outbreaks of deadly infectious diseases caused by pathogenic microorganisms have threatened public health worldwide and significantly motivated scientists to satisfy an urgent need for a rapid and accurate detection of pathogens. Traditionally, the culture-based technique is considered as the gold standard for pathogen detection, yet it has a long turnaround time due to the overnight culturing and pathogen isolation. Alternatively, nucleic acid amplification tests provide a relatively shorter turnaround time to identify whether pathogens exist in individuals with high sensitivity and high specificity. In most cases, nucleic acid amplification tests undergo three steps: sample preparation, nucleic acid amplification, and signal transduction. Despite the explosive advancement in nucleic acid amplification and signal transduction technologies, the complex and labor-intensive sample preparation steps remain a bottleneck to create a transformative integrated point-of-care (POC) molecular diagnostic device. Researchers have attempted to simplify and integrate the sample preparations for nucleic acid-based molecular diagnostic devices with innovative progress in integration strategies, engineered materials, reagent storages, and fluid actuation. Therefore, understanding the know-how and obtaining truthful knowledge of existing integrated POC molecular diagnostic devices comprising sample preparations, nucleic acid amplification, and signal transduction can generate innovative solutions to achieve personalized precision medicine and improve global health.In this Account, we discuss the challenges of automated sample preparation solutions integrated with nucleic acid amplification and signal transduction for rapid and precise home diagnostics. Blood, nasal swab, saliva, urine, and stool are emphasized as the most commonly used clinical samples for integrated POC molecular diagnostics of infectious diseases. Even though these five types of samples possess relatively correlated biomarkers due to the human body's circulatory system, each shows unique properties and exclusive advantages for molecular diagnostics in specific situations, which are included in this Account. We examine different integrated POC devices for sample preparation, which includes pathogen isolation and enrichment from the crude sample and nucleic acid purification from isolated pathogens. We present the promising on-chip integration approaches for nucleic acid amplification. We also investigate the on-chip integration methods for reagent storage, which is crucial to simplify the manual operation for end-users. Finally, we present several integrated POC molecular diagnostic devices for infectious diseases. The integrated sample preparation and nucleic acid amplification approach reviewed here can potentially impact the next generation of POC molecular home diagnostic chips, which will significantly impact public health, emergency medicine, and global biosecurity.

Isothermal Amplification Technology for Disease Diagnosis

Current and Future Perspectives on Isothermal Nucleic Acid Amplification Technologies for Diagnosing Infections

Isothermal nucleic acid amplification and its uses in modern diagnostic technologies

RNA-based isothermal amplification technology and its clinical application in pathogen infection

Isothermal Amplification Technologies for the Detection of Foodborne Pathogens

Isothermal nucleic acid amplification technology for rapid detection of virus

Principles and Applications of Loop-Mediated Isothermal Amplification to Point-of-Care Tests

Progress on isothermal amplification technologies and their applications in pathogen biological research

Isothermal Amplification Technology for Diagnosis of COVID-19: Current Status and Future Prospects

Advances in nucleic acid amplification techniques (NAATs): COVID-19 point-of-care diagnostics as an example

Assessment of eight nucleic acid amplification technologies for potential use to detect infectious agents in low-resource settings

[Methods of isothermal nucleic acid amplification-based microfluidic chips for pathogen microorganism detection]

Molecular isothermal techniques for combating infectious diseases: towards low-cost point-of-care diagnostics

Integrated Point-of-Care Molecular Diagnostic Devices for Infectious Diseases

Emerging ultrafast nucleic acid amplification technologies for next-generation molecular diagnostics

Research progress and prospects of nucleic acid isothermal amplification technology

Microfluidic chip and isothermal amplification technologies for the detection of pathogenic nucleic acid

Multiple strategies to improve sensitivity, speed and robustness of isothermal nucleic acid amplification for rapid pathogen detection

Enzyme-Assisted Nucleic Acid Detection for Infectious Disease Diagnostics: Moving toward the Point-of-Care

Real-Time Detection of Amplification Products Through Fluorescence Quenching or Energy Transfer

Isothermal nucleic acid amplification for food safety analysis